Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease

dc.contributor.authorLin, Tesudeu
dc.contributor.authorBrunner, Thomas
dc.contributor.authorTietz, Briandeu
dc.contributor.authorMadsen, Jilldeu
dc.contributor.authorBonfoco, Emanueladeu
dc.contributor.authorReaves, Miriamdeu
dc.contributor.authorHuflejt, Margaretdeu
dc.contributor.authorGreen, Douglas R.deu
dc.date.accessioned2011-07-29T08:30:11Zdeu
dc.date.available2011-07-29T08:30:11Zdeu
dc.date.issued1998deu
dc.description.abstractIn vitro studies have demonstrated that intestinal intraepithelial lymphocytes (IEL) are constitutively cytotoxic; however, the mechanism and target of their cytotoxicity are unknown. Apoptosis of intestinal epithelial cells (IEC) and an increase in IEL numbers are classical signs of intestinal graft-versus-host disease (GVHD), although whether IEL can mediate IEC apoptosis directly in GVHD is unclear. Recent evidence suggests that target epithelial organ injury observed in GVHD is predominantly Fas-mediated; therefore, we investigated the possibility that IEL induce apoptosis of IEC through a Fas-mediated mechanism. Here, we demonstrate that the IEL isolated from normal mice readily display potent Fas ligand (FasL)-mediated killing activity after CD3 stimulation, and that IEC express Fas, suggesting that IEC are potential targets for FasL-mediated killing by IEL. In vitro, IEL isolated from GVHD mice have markedly increased FasL-mediated killing potential and are spontaneously cytolytic toward host-derived tumor cells predominantly through a Fas-mediated pathway. In vivo transfer of IEL isolated from GVHD mice induced significantly more IEC apoptosis in F1 wild-type mice than in Fas-defective F1lpr mice. Thus, these results demonstrate that FasL-mediated death of IEC by IEL is a major mechanism of IEC apoptosis seen in GVHD.
dc.description.versionpublished
dc.identifier.citationFirst publ. in: The journal of clinical investigation : JCI ; 101 (1998), 3. - S. 570-577deu
dc.identifier.doi10.1172/JCI896
dc.identifier.pmid9449689
dc.identifier.ppn352885696deu
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/14307
dc.language.isoengdeu
dc.legacy.dateIssued2011-07-29deu
dc.rightsterms-of-usedeu
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/deu
dc.subject.ddc570deu
dc.titleFas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host diseaseeng
dc.typeJOURNAL_ARTICLEdeu
dspace.entity.typePublication
kops.citation.bibtex
@article{Lin1998ligan-14307,
  year={1998},
  doi={10.1172/JCI896},
  title={Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease},
  number={3},
  volume={101},
  issn={0021-9738},
  journal={The journal of clinical investigation : JCI},
  pages={570--577},
  author={Lin, Tesu and Brunner, Thomas and Tietz, Brian and Madsen, Jill and Bonfoco, Emanuela and Reaves, Miriam and Huflejt, Margaret and Green, Douglas R.}
}
kops.citation.iso690LIN, Tesu, Thomas BRUNNER, Brian TIETZ, Jill MADSEN, Emanuela BONFOCO, Miriam REAVES, Margaret HUFLEJT, Douglas R. GREEN, 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease. In: The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896deu
kops.citation.iso690LIN, Tesu, Thomas BRUNNER, Brian TIETZ, Jill MADSEN, Emanuela BONFOCO, Miriam REAVES, Margaret HUFLEJT, Douglas R. GREEN, 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease. In: The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14307">
    <dc:creator>Brunner, Thomas</dc:creator>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Brunner, Thomas</dc:contributor>
    <dcterms:title>Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease</dcterms:title>
    <dc:contributor>Tietz, Brian</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14307/2/1998_Lin_Fas%20Ligand%20med%20kill.pdf"/>
    <dc:creator>Huflejt, Margaret</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-07-29T08:30:11Z</dcterms:available>
    <dcterms:issued>1998</dcterms:issued>
    <dc:language>eng</dc:language>
    <dc:contributor>Lin, Tesu</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Bonfoco, Emanuela</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:bibliographicCitation>First publ. in: The journal of clinical investigation : JCI ; 101 (1998), 3. - S. 570-577</dcterms:bibliographicCitation>
    <dc:contributor>Madsen, Jill</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-07-29T08:30:11Z</dc:date>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14307/2/1998_Lin_Fas%20Ligand%20med%20kill.pdf"/>
    <dc:creator>Tietz, Brian</dc:creator>
    <dc:creator>Reaves, Miriam</dc:creator>
    <dc:creator>Madsen, Jill</dc:creator>
    <dc:contributor>Huflejt, Margaret</dc:contributor>
    <dc:contributor>Reaves, Miriam</dc:contributor>
    <dcterms:abstract>In vitro studies have demonstrated that intestinal intraepithelial lymphocytes (IEL) are constitutively cytotoxic; however, the mechanism and target of their cytotoxicity are unknown. Apoptosis of intestinal epithelial cells (IEC) and an increase in IEL numbers are classical signs of intestinal graft-versus-host disease (GVHD), although whether IEL can mediate IEC apoptosis directly in GVHD is unclear. Recent evidence suggests that target epithelial organ injury observed in GVHD is predominantly Fas-mediated; therefore, we investigated the possibility that IEL induce apoptosis of IEC through a Fas-mediated mechanism. Here, we demonstrate that the IEL isolated from normal mice readily display potent Fas ligand (FasL)-mediated killing activity after CD3 stimulation, and that IEC express Fas, suggesting that IEC are potential targets for FasL-mediated killing by IEL. In vitro, IEL isolated from GVHD mice have markedly increased FasL-mediated killing potential and are spontaneously cytolytic toward host-derived tumor cells predominantly through a Fas-mediated pathway. In vivo transfer of IEL isolated from GVHD mice induced significantly more IEC apoptosis in F1 wild-type mice than in Fas-defective F1lpr mice. Thus, these results demonstrate that FasL-mediated death of IEC by IEL is a major mechanism of IEC apoptosis seen in GVHD.</dcterms:abstract>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Green, Douglas R.</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14307"/>
    <dc:contributor>Bonfoco, Emanuela</dc:contributor>
    <dc:creator>Lin, Tesu</dc:creator>
    <dc:contributor>Green, Douglas R.</dc:contributor>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.flag.knbibliographyfalse
kops.identifier.nbnurn:nbn:de:bsz:352-143078deu
kops.sourcefieldThe journal of clinical investigation : JCI. 1998, <b>101</b>(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896deu
kops.sourcefield.plainThe journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896deu
kops.sourcefield.plainThe journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896eng
kops.submitter.emailregine.winter@uni-konstanz.dedeu
relation.isAuthorOfPublicationf61b843f-0378-4683-b89b-70ad6aec10ea
relation.isAuthorOfPublication.latestForDiscoveryf61b843f-0378-4683-b89b-70ad6aec10ea
source.bibliographicInfo.fromPage570
source.bibliographicInfo.issue3
source.bibliographicInfo.toPage577
source.bibliographicInfo.volume101
source.identifier.issn0021-9738
source.periodicalTitleThe journal of clinical investigation : JCI

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
1998_Lin_Fas Ligand med kill.pdf
Größe:
549.46 KB
Format:
Adobe Portable Document Format
1998_Lin_Fas Ligand med kill.pdf
1998_Lin_Fas Ligand med kill.pdfGröße: 549.46 KBDownloads: 278

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
1.92 KB
Format:
Plain Text
Beschreibung:
license.txt
license.txtGröße: 1.92 KBDownloads: 0